OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Identification of three m6A‐related mRNAs signature and risk score for the prognostication of hepatocellular carcinoma
Zedong Li, Fazhan Li, Yu Peng, et al.
Cancer Medicine (2020) Vol. 9, Iss. 5, pp. 1877-1889
Open Access | Times Cited: 63

Showing 1-25 of 63 citing articles:

The potential role of RNA N6-methyladenosine in Cancer progression
Tianyi Wang, Shan Kong, Mei Tao, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 798

Functions, mechanisms, and therapeutic implications of METTL14 in human cancer
Qian Guan, Huiran Lin, Lei Miao, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 83

Critical roles and clinical perspectives of RNA methylation in cancer
Ganglei Li, Qinfan Yao, Peixi Liu, et al.
MedComm (2024) Vol. 5, Iss. 5
Open Access | Times Cited: 17

The role of N6-methyladenosine mRNA in the tumor microenvironment
Min Li, Xuan Zha, Shengjun Wang
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2021) Vol. 1875, Iss. 2, pp. 188522-188522
Closed Access | Times Cited: 101

RNA m6A Modification in Cancers: Molecular Mechanisms and Potential Clinical Applications
Chang Gu, Xin Shi, Chenyang Dai, et al.
The Innovation (2020) Vol. 1, Iss. 3, pp. 100066-100066
Open Access | Times Cited: 98

The emerging molecular mechanism of m6A modulators in tumorigenesis and cancer progression
Shuiping Liu, Qiujie Li, Ke Chen, et al.
Biomedicine & Pharmacotherapy (2020) Vol. 127, pp. 110098-110098
Open Access | Times Cited: 78

Expression of m6A Regulators Correlated With Immune Microenvironment Predicts Therapeutic Efficacy and Prognosis in Gliomas
Shengchao Xu, Lu Tang, Gan Dai, et al.
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 68

Analysis of m6A RNA Methylation-Related Genes in Liver Hepatocellular Carcinoma and Their Correlation with Survival
Yong Li, Dandan Qi, Baoli Zhu, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 3, pp. 1474-1474
Open Access | Times Cited: 51

The molecular structure and biological functions of RNA methylation, with special emphasis on the roles of RNA methylation in autoimmune diseases
Wanwan Zhou, Xiao Wang, Jun Chang, et al.
Critical Reviews in Clinical Laboratory Sciences (2021) Vol. 59, Iss. 3, pp. 203-218
Closed Access | Times Cited: 48

Comprehensive analysis of N6-methylandenosine regulators and m6A-related RNAs as prognosis factors in colorectal cancer
Wei Li, Yingchao Gao, Xiaojing Jin, et al.
Molecular Therapy — Nucleic Acids (2021) Vol. 27, pp. 598-610
Open Access | Times Cited: 48

The role, mechanism, and application of RNA methyltransferase METTL14 in gastrointestinal cancer
Bin Shi, Weiwei Liu, Ke Yang, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 38

Identification and validation of m6A RNA methylation regulators with clinical prognostic value in Papillary thyroid cancer
Xinyi Wang, Xiaorui Fu, Junjia Zhang, et al.
Cancer Cell International (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 47

The functional roles, cross-talk and clinical implications of m6A modification and circRNA in hepatocellular carcinoma
Sha Qin, Yitao Mao, Chen Xue, et al.
International Journal of Biological Sciences (2021) Vol. 17, Iss. 12, pp. 3059-3079
Open Access | Times Cited: 41

RNA Methylations in Cardiovascular Diseases, Molecular Structure, Biological Functions and Regulatory Roles in Cardiovascular Diseases
Wanwan Zhou, Changhui Wang, Jun Chang, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 35

The role of RNA modification in hepatocellular carcinoma
Qiang Feng, Dongxu Wang, Tianyi Xue, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 23

The emerging roles of m6A modification in liver carcinogenesis
Xue‐Yin Pan, Cheng Huang, Jun Li
International Journal of Biological Sciences (2020) Vol. 17, Iss. 1, pp. 271-284
Open Access | Times Cited: 38

Role of histone lactylation interference RNA m6A modification and immune microenvironment homeostasis in pulmonary arterial hypertension
Shuaishuai Zhao, Jinlong Liu, Qicai Wu, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 11

Large-scale transcriptome analysis identified RNA methylation regulators as novel prognostic signatures for lung adenocarcinoma
Lei Sun, Wenke Liu, Xiaowei Du, et al.
Annals of Translational Medicine (2020) Vol. 8, Iss. 12, pp. 751-751
Open Access | Times Cited: 32

Function and clinical significance of N6-methyladenosine in digestive system tumours
Junchao Huang, Yingjie Shao, Wendong Gu
Experimental Hematology and Oncology (2021) Vol. 10, Iss. 1
Open Access | Times Cited: 24

Role of N6-Methyladenosine (m6A) Methylation Regulators in Hepatocellular Carcinoma
Nanfang Qu, Xiaotong Bo, Bin Li, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 24

Comprehensive Analysis of N6-Methyladenosine (m6A) Writers, Erasers, and Readers in Cervical Cancer
Mateja Condic, Damian J. Ralser, Niklas Klümper, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 13, pp. 7165-7165
Open Access | Times Cited: 17

N6-Methylandenosine-Related lncRNA Signature Is a Novel Biomarkers of Prognosis and Immune Response in Colon Adenocarcinoma Patients
Peiling Zhang, Guolong Liu, Lin Lü
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 22

Page 1 - Next Page

Scroll to top